# Trade Mark Journal No.2026/002 9 January 2026

## WO0000001892897 (5)

Office of origin: United States of America

Date of International Registration:11 November 2025
Date of designation in the UK: 11 November 2025

International priority date claimed: 23 May 2025 (United States of America) (99200798)

Class 5
  Imaging agents for near infrared radiation (NIR) intraoperative imaging; radiopharmaceutical imaging and detection agents for identifying and treating cancer; imaging agents for use with medical imaging equipment for use in humans and animals to detect tumors and cancers, and to assist in visualizing tissues during surgery or endoscopy procedures for diagnostics or therapy delivery.

Vergent Bioscience, Inc.

Representative: Kevin King Eversheds Sutherland (US) LLP, 999 Peachtree Street, NE, Suite 2300, Atlanta GA 30309, UNITED STATES OF AMERICA